Intel Corporation (NASDAQ:INTC) Shares Sold by Aspiriant LLC

Aspiriant LLC decreased its stake in shares of Intel Corporation (NASDAQ:INTC) by 41.4% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,882 shares of the chip maker’s stock after selling 9,092 shares during the period. Aspiriant LLC’s holdings in Intel were worth $293,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Synergy Investment Management LLC bought a new position in shares of Intel during the fourth quarter worth about $27,000. Vermillion Wealth Management Inc. bought a new position in Intel in the fourth quarter worth about $27,000. BankPlus Trust Department bought a new position in Intel in the fourth quarter worth about $28,000. Conquis Financial LLC bought a new position in Intel in the fourth quarter worth about $32,000. Finally, Pillar Financial Advisors LLC bought a new position in Intel in the fourth quarter worth about $34,000. Institutional investors own 64.53% of the company’s stock.

Intel Price Performance

NASDAQ INTC opened at $21.49 on Thursday. Intel Corporation has a 12 month low of $17.67 and a 12 month high of $37.16. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.31 and a quick ratio of 0.93. The firm has a market capitalization of $93.74 billion, a PE ratio of -4.80 and a beta of 1.12. The company’s 50 day simple moving average is $20.47 and its 200 day simple moving average is $21.10.

Intel (NASDAQ:INTC) last posted its quarterly earnings data on Thursday, April 24th. The chip maker reported $0.13 EPS for the quarter, beating analysts’ consensus estimates of $0.01 by $0.12. Intel had a negative net margin of 36.19% and a negative return on equity of 3.15%. The business had revenue of $12.67 billion for the quarter, compared to analyst estimates of $12.26 billion. During the same quarter last year, the business earned $0.18 earnings per share. The business’s revenue for the quarter was down .4% on a year-over-year basis. As a group, equities research analysts forecast that Intel Corporation will post -0.11 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. Citigroup reissued a “sell” rating on shares of Intel in a report on Friday, April 25th. Morgan Stanley cut their target price on shares of Intel from $25.00 to $23.00 and set an “equal weight” rating on the stock in a report on Friday, April 25th. Cantor Fitzgerald cut their target price on shares of Intel from $29.00 to $20.00 and set a “neutral” rating on the stock in a report on Monday, April 21st. Needham & Company LLC reissued a “hold” rating on shares of Intel in a report on Friday, April 25th. Finally, Barclays reissued a “reduce” rating on shares of Intel in a report on Tuesday, April 22nd. Six research analysts have rated the stock with a sell rating, twenty-five have given a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, Intel has a consensus rating of “Hold” and a consensus price target of $21.57.

Intel Profile

Intel Corporation designs, develops, manufactures, markets, and sells computing and related products and services worldwide. It operates through Client Computing Group, Data Center and AI, Network and Edge, Mobileye, and Intel Foundry Services segments. The company's products portfolio comprises central processing units and chipsets, system-on-chips (SoCs), and multichip packages; mobile and desktop processors; hardware products comprising graphics processing units (GPUs), domain-specific accelerators, and field programmable gate arrays (FPGAs); and memory and storage, connectivity and networking, and other semiconductor products.